文献速递神经MR

7T磁共振波谱在高级别胶质瘤中的应用

Application of 7T MRS to High-Grade Gliomas.
PubMed 文献 · AJNR Am J Neuroradiol · 2022-05-26

本文综述了7T磁共振波谱(包括单一体素波谱和磁共振波谱成像)在高级别胶质瘤中的应用,旨在明确其提供的代谢信息、最佳波谱序列及改进方向。7T MRS具有更高信噪比、 modestly改善的空间分辨率和更好的重叠共振分辨能力,并产生更低的Cramér-Rao下界值,有助于量化IDH1/2胶质瘤中的D-2-羟基戊二酸,并以更高敏感度和特异度分离可变谷氨酸、升高的谷氨酰胺和升高的甘氨酸。7T MRS可能更好地表征肿瘤浸润和治疗效果,但需进一步研究。

要点

  • 7T MRS提供更高信噪比、 modestly改善的空间分辨率和更好的重叠共振分辨能力。
  • 7T MRS产生更低的Cramér-Rao下界值,有助于量化IDH1/2胶质瘤中的D-2-羟基戊二酸。
  • 7T MRS可能更好地表征高级别胶质瘤的肿瘤浸润和治疗效果,但需进一步研究。

核心结论

  • 7T MRS可能增进对高级别胶质瘤代谢的理解,具有更低的Cramér-Rao下界值和更好的小代谢物信号测量;然而7T在临床上尚未广泛使用,需要技术改进。

研究设计与样本

  • 综述;通过PubMed检索文献,检索词包括「high-grade glioma」「malignant glioma」「glioblastoma」「anaplastic astrocytoma」「7T」「MR spectroscopy」「MR spectroscopic imaging」。

关键影像表现/征象

  • 7T MRS提供更高的信噪比、 modestly改善的空间分辨率和更好的重叠共振分辨能力。
  • 7T MRS产生更低的Cramér-Rao下界值。
  • 这些特征有助于量化IDH1和IDH2胶质瘤中的D-2-羟基戊二酸,并以更高敏感度和特异度分离可变谷氨酸、升高的谷氨酰胺和升高的甘氨酸。
  • 7T MRS可能更好地表征高级别胶质瘤的肿瘤浸润和治疗效果,但需进一步研究。

诊断标准与关键数值

  • 7T MRS以更高敏感度和特异度分离可变谷氨酸、升高的谷氨酰胺和升高的甘氨酸。
  • 7T MRS产生更低的Cramér-Rao下界值,有助于量化IDH1和IDH2胶质瘤中的D-2-羟基戊二酸。

临床应用与阅片要点

  • 7T MRS可分离出可能成为高级别胶质瘤治疗靶点的代谢物,可能带来更广泛的神经肿瘤学应用。
  • 7T在临床上尚未广泛使用,需要技术改进。

局限性

  • 文献尚未总结7T MRS用于可视化高级别胶质瘤的应用。
  • 需要进一步研究以确认7T MRS是否更好地表征肿瘤浸润和治疗效果。
  • 7T MRS将受益于增加样本量、减少场不均匀性、特定吸收率和采集时间,以及先进的编辑技术。
  • 7T在临床上尚未广泛使用,需要技术改进。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

MRS, including single-voxel spectroscopy and MR spectroscopic imaging, captures metabolites in high-grade gliomas. Emerging evidence indicates that 7T MRS may be more sensitive to aberrant metabolic activity than lower-field strength MRS. However, the literature on the use of 7T MRS to visualize high-grade gliomas has not been summarized. We aimed to identify metabolic information provided by 7T MRS, optimal spectroscopic sequences, and areas for improvement in and new applications for 7T MRS. Literature was found on PubMed using "high-grade glioma," "malignant glioma," "glioblastoma," "anaplastic astrocytoma," "7T," "MR spectroscopy," and "MR spectroscopic imaging." 7T MRS offers higher SNR, modestly improved spatial resolution, and better resolution of overlapping resonances. 7T MRS also yields reduced Cramér-Rao lower bound values. These features help to quantify D-2-hydroxyglutarate in isocitrate dehydrogenase 1 and 2 gliomas and to isolate variable glutamate, increased glutamine, and increased glycine with higher sensitivity and specificity. 7T MRS may better characterize tumor infiltration and treatment effect in high-grade gliomas, though further study is necessary. 7T MRS will benefit from increased sample size; reductions in field inhomogeneity, specific absorption rate, and acquisition time; and advanced editing techniques. These findings suggest that 7T MRS may advance understanding of high-grade glioma metabolism, with reduced Cramér-Rao lower bound values and better measurement of smaller metabolite signals. Nevertheless, 7T is not widely used clinically, and technical improvements are necessary. 7T MRS isolates metabolites that may be valuable therapeutic targets in high-grade gliomas, potentially resulting in wider ranging neuro-oncologic applications.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. McCarthy, Verma, Hangel, et al. Application of 7T MRS to High-Grade Gliomas. AJNR Am J Neuroradiol. 2022. PMID: 35618424. doi:10.3174/ajnr.A7502

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。